Evaluating cancer costs in NCI trials

Area of Science:

• Health Economics
• Oncology
• Clinical Trial Management

Background:

• Economic evaluation is vital for cancer treatment strategy assessment.
• Data on cost and effectiveness of cancer therapies inform clinical and policy decisions.
• Optimal treatment strategies require robust economic data.

Purpose of the Study:

• To outline procedures for assessing healthcare costs within National Cancer Institute (NCI) clinical trials.
• To review the economic framework for clinical trial assessment.
• To present a proposed strategy for economic assessment in oncology.

Main Methods:

• Review of the economic framework for clinical trial assessment.
• Development and proposal of a specific strategy for economic assessment.
• Implementation of the proposed assessment design within NCI trials.

Main Results:

• A set of procedures for assessing costs in NCI clinical trials was successfully outlined and implemented.
• The economic framework and proposed strategy were reviewed.
• Published results demonstrate the successful implementation of the economic assessment design.

Conclusions:

• Economic assessment procedures are essential for NCI clinical trials.
• The implemented strategy provides a tool for determining optimal cancer treatment strategies.
• Findings support informed decision-making for clinicians, patients, and health policy makers.